Untangle the complexity of cancer with true multi-omics.
Gain the true single-cell picture to enable precise understanding
The Tapestri Platform is the only system capable of simultaneously providing both genotype and phenotype data from the same cell, across thousands of single cells. With DNA as a foundation, our proprietary two-step microfluidic workflow enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins. Meet the complexity of cancer with true multi-omics analysis.
The Tapestri Platform: Unravel cancer’s complexity with true single-cell multi-omics
Two steps. DNA + any analyte. Endless possibilities.
Our novel two-step microfluidic workflow is foundational to access DNA and protein in single cells, providing a true multi-omics picture. Combining two assays in a single integrated workflow saves costs and time, accelerating research and drug development pipelines.
Targeted and customizable.
Leverage curated pre-designed panels of DNA and surface protein targets, or create custom panels to suit your needs. Our optimized AI design pipeline will ensure a panel with high uniformity delivered in just weeks.
Confidence in a comprehensive end-to-end workflow.
With core reagent and cartridge kits to take you from single cells to a sequencing-ready library, leverage optimized analysis tools to convert your complex multi-dimensional, multi-analyte data to actionable insights.
The Complete Tapestri Workflow
Integrate seamlessly into your existing NGS workflow with sample prep and analysis solutions using the Tapestri single-cell sequencing platform
With our single-cell sequencing platform use the Tapestri instrument, reagents and consumables up-front of your NGS system and then Tapestri Pipeline and Tapestri Insights software for data analysis and visualization.
Library Prep with Tapestri
Access high quality data with a unique two-step microfluidic workflow
Based on a novel two-step microfluidic workflow, the Tapestri Platform can access DNA and protein in single cells to give you true multi-omics. Each reaction in the two-step workflow is discretely optimized: isolation of DNA from the cell and oligo-conjugate antibodies in the first step, followed by targeted multiplex PCR in the second step.
